Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
79 hedge funds and large institutions have $11.2M invested in Ampio Pharmaceuticals Inc. in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 6 closing their positions.
300% more call options, than puts
Call options by funds: $380K | Put options by funds: $95K
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
63% more capital invested
Capital invested by funds: $6.91M → $11.2M (+$4.33M)
3% more funds holding
Funds holding: 77 → 79 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$649K |
| 2 |
PCMC
Private Capital Management (Colorado)
Denver,
Colorado
|
+$308K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$200K |
| 4 |
BlackRock
New York
|
+$186K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$98.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
-$639K |
| 2 |
HC
HNP Capital
Rochester,
New York
|
-$200K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$86K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$42.4K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$21.5K |
AMPE Hedge Fund Activity: Q2 2020 in Review
79 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2020, worth a combined $11.2M — up 63% from $6.91M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AMPE positions and 6 closed out — a net gain of 4 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $649K. The largest seller was Arax Advisory Partners, cutting an estimated $639K.
- 79 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2020, up from 77 in Q1 2020.
- Funds reported $11.2M of Ampio Pharmaceuticals Inc. stock for Q2 2020, up 63% quarter-over-quarter.
- 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2020 and 6 closed out, a net change of +4 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2020 was Bridgeway Capital Management, an estimated $649K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2020 was Arax Advisory Partners, an estimated $639K sold.
Based on aggregated 13F filings for Q2 2020.